News|Articles|December 2, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-12-07-2016
  • Volume 11
  • Issue 12

Recipharm Collaborates with Laccure AB

Recipharm and Laccure AB signed a commercial collaboration for the manufacture and delivery of Laccure’s bacterial vaginosis treatment.

On Dec. 1, 2016 Recipharm announced that it has entered a commercial collaboration with Laccure AB for the manufacture and delivery of Laccure Pessary, a non-prescription vaginal tablet for the treatment of bacterial vaginosis. Laccure Pessary will be manufactured, packaged, and distributed globally from Recipharm’s facility in Karlskoga that specializes in the production of semi-solid products. Recipharm and Laccure AB have now signed an agreement for commercial production of Laccure Pessary, and the exact date for the launch will be announced in 2017. Laccure Pessary is based on a patented substance that releases lactic acid.

Source: Recipharm

 


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.